Clinical utility of anti-C1q antibody in primary and secondary vasculitic conditions

OBJECTIVE: Anti-C1q antibodies (Anti-C1q Ab) are seen in hypocomplementemic urticarial vasculitis syndrome (HUVS), infection-associated vasculitis such as hepatitis C virus-related vasculitis and in autoimmune diseases such as rheumatoid vasculitis, polyarteritis nodosa, giant cell arteritis, vascul...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Health Sci (Qassim)
Asıl Yazarlar: Jayakanthan, Kabeerdoss, Gupta, and Nikhil, Mathew, John, Ravindran, Raheesh, Mahasampth, Gowri, Danda, Debashish
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Qassim Uninversity 2017
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5669508/
https://ncbi.nlm.nih.gov/pubmed/29114186
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller